Last reviewed · How we verify
NCT05258838: PsoTReg
Tunisian National Registry on Psoriasis
trial in Psoriasis in 1,100 participants. Completed in 31 December 2024.
31 December 2024
Quick facts
| Lead sponsor | Dacima Consulting |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,100 |
| Start date | 12 July 2022 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across Tunisia |
Conditions studied
- Psoriasis — all drugs for Psoriasis →
Sponsor
Dacima Consulting
Who can join
Eligibility, any sex, with Psoriasis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
National cross-sectional multicentric study to describe the epidemiological characteristics of patients with Psoriasis in Tunisia
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05258838
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Psoriasis
Currently open trials in the same condition.
- NCT07471048 — A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoria · NA · recruiting
- NCT07449234 — A Study of Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasis · recruiting
- NCT07234838 — Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO) · recruiting
- NCT07194200 — Safety and Efficacy of Lactobacillus Plantarum for Psoriasis: A Randomized Double-Blind Placebo-Controlled Trial · Phase 2 · recruiting
- NCT07250997 — PALLAS Laser for Skin Diseases · NA · recruiting
Other Dacima Consulting trials
Trials by the same sponsor.
- NCT07034274 — National Tunisian Clinical Registry on CardioVascular Secondary Prevention Clinical · recruiting
- NCT06934499 — Tunisian Lung Cancer Study · recruiting
- NCT06825533 — The Prevalence of Prediabetes in Primary Care Medicine in Tunisia · not yet recruiting
- NCT06445036 — Tunisian Clinical Registry on Hypoparathyroidism and Pseudo-hypoparathyroidism · not yet recruiting
- NCT05991089 — Tunisian Clinical Registry on Chronic Kidney Disease in Hypertensive Patients · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05258838 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dacima Consulting
- Last refreshed: 17 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05258838.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing